Gates Foundation Commits US$2.5 Billion to Women’s Health

The Bill & Melinda Gates Foundation announced a US$2.5 billion commitment through 2030 to accelerate R&D on women’s health. The initiative aims to advance pver 40 innovations across five underfunded areas that disproportionately affect women, especially in low and middle-income countries.

“Investing in women’s health yields intergenerational returns, from healthier families to stronger economies,” says Bill Gates, Co-Chair, Bill & Melinda Gates Foundation. “Too many women still suffer or die from preventable causes. That must change, but we cannot do it alone.”

According to the foundation, women's health conditions have long been overlooked, poorly diagnosed, or misunderstood. This new investment seeks to correct the historical imbalance in health R&D by prioritizing areas with significant scientific gaps and societal impacts.

Women's health remains one of the most underfunded areas in global health innovation. A 2021 McKinsey & Company analysis found that only 1% of health research funding is allocated to female-specific conditions outside of oncology. Diseases like preeclampsia, endometriosis, gestational diabetes, and menopause remain poorly understood, though they affect millions worldwide.

The five focus areas include obstetric care and maternal immunization, maternal health and nutrition, gynecological and menstrual health, contraceptive innovation, and diagnosis and treatment of sexually transmitted infections (STIs), including HIV prevention. The foundation plans to support product development, data generation, and policy advocacy to increase adoption once new tools are approved.

Some targeted innovations involve non-hormonal contraceptives, advanced therapies for preeclampsia, and research into the vaginal microbiome. The selection of priority areas was informed by epidemiological data, direct feedback from women in underserved regions, and the persistently high rates of misdiagnosis due to limited clinical training and resources.

The foundation is calling on governments, the private sector, and other philanthropic actors to co-invest and help close the research and funding gap. By prioritizing innovation in these areas, the Gates Foundation aims not only to improve outcomes for women but to catalyze broader economic and public health benefits.

Evidence suggests that every dollar invested in women’s health can generate US$3 in economic growth, and closing the gender health gap could add US$1 trillion to the global economy annually by 2040.

The Gates Foundation’s long-term goals include eliminating preventable maternal and neonatal deaths, reducing the burden of infectious diseases, and lifting millions out of poverty. It builds on two decades of work in maternal and child health and aims to support the development and scale-up of vital products, such as the HPV vaccine and other essential health tools